Free allocation of stock warrants
Following the approval by the shareholders of the 3rd resolution at the Shareholders' Meeting on 26/10/2017, the company issued redeemable share warrants (BSAR C).
General Meeting of shareholders on 26/10/2017
- Approval of all Resolutions
On October 26, 2017 (by 2nd call), under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered its shareholders representing 37,956,617 shares (present, represented or postal votes), corresponding to 24.95% of the capital.
2017 half-year Results as at 30 June 2017
Europlasma today announces its results for the six months ended June 30, 2017, which were subject to a limited review by Auditors and were approved by the Board of Directors on October 24, 2017.
General Meeting of Shareholders, new call
On 10 October 2017, under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered shareholders representing 30,253,122 shares (present, represented or postal votes), corresponding to 19.88% of the share capital.
Number of shares and voting rights as at 30/09/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September.
ERRATUM
The 3rd resolution regarding the conditions of issue and subscription of the BSAR C as mentioned in the text of the resolutions addressed to the registered shareholders contained material errors.